145 related articles for article (PubMed ID: 23146242)
1. The synthesis and characterization of a nuclear membrane affinity chromatography column for the study of human breast cancer resistant protein (BCRP) using nuclear membranes obtained from the LN-229 cells.
Habicht KL; Frazier C; Singh N; Shimmo R; Wainer IW; Moaddel R
J Pharm Biomed Anal; 2013 Jan; 72():159-62. PubMed ID: 23146242
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a multiple endogenously expressed adenosine triphosphate-binding cassette transporters using nuclear and cellular membrane affinity chromatography columns.
Habicht KL; Singh NS; Khadeer MA; Shimmo R; Wainer IW; Moaddel R
J Chromatogr A; 2014 Apr; 1339():80-85. PubMed ID: 24642394
[TBL] [Abstract][Full Text] [Related]
3. The synthesis and characterization of cellular membrane affinity chromatography columns for the study of human multidrug resistant proteins MRP1, MRP2 and human breast cancer resistant protein BCRP using membranes obtained from Spodoptera frugiperda (Sf9) insect cells.
Bhatia PA; Moaddel R; Wainer IW
Talanta; 2010 Jun; 81(4-5):1477-81. PubMed ID: 20441926
[TBL] [Abstract][Full Text] [Related]
4. Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence.
Wang H; Lee EW; Cai X; Ni Z; Zhou L; Mao Q
Biochemistry; 2008 Dec; 47(52):13778-87. PubMed ID: 19063604
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.
Scheffer GL; Maliepaard M; Pijnenborg AC; van Gastelen MA; de Jong MC; Schroeijers AB; van der Kolk DM; Allen JD; Ross DD; van der Valk P; Dalton WS; Schellens JH; Scheper RJ
Cancer Res; 2000 May; 60(10):2589-93. PubMed ID: 10825126
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells.
Bhatia P; Bernier M; Sanghvi M; Moaddel R; Schwarting R; Ramamoorthy A; Wainer IW
Xenobiotica; 2012 Aug; 42(8):748-55. PubMed ID: 22401348
[TBL] [Abstract][Full Text] [Related]
7. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.
Bailey-Dell KJ; Hassel B; Doyle LA; Ross DD
Biochim Biophys Acta; 2001 Sep; 1520(3):234-41. PubMed ID: 11566359
[TBL] [Abstract][Full Text] [Related]
8. Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.
Ni Z; Bikadi Z; Shuster DL; Zhao C; Rosenberg MF; Mao Q
Biochemistry; 2011 Sep; 50(37):8057-66. PubMed ID: 21854076
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3).
Paturi DK; Kwatra D; Ananthula HK; Pal D; Mitra AK
Int J Pharm; 2010 Jan; 384(1-2):32-8. PubMed ID: 19782742
[TBL] [Abstract][Full Text] [Related]
10. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis.
Ifergan I; Shafran A; Jansen G; Hooijberg JH; Scheffer GL; Assaraf YG
J Biol Chem; 2004 Jun; 279(24):25527-34. PubMed ID: 15047700
[TBL] [Abstract][Full Text] [Related]
11. The development of mitochondrial membrane affinity chromatography columns for the study of mitochondrial transmembrane proteins.
Habicht KL; Singh NS; Indig FE; Wainer IW; Moaddel R; Shimmo R
Anal Biochem; 2015 Sep; 484():154-61. PubMed ID: 26049098
[TBL] [Abstract][Full Text] [Related]
12. Development of an immobilized P-glycoprotein stationary phase for on-line liquid chromatographic determination of drug-binding affinities.
Zhang Y; Leonessa F; Clarke R; Wainer IW
J Chromatogr B Biomed Sci Appl; 2000 Feb; 739(1):33-7. PubMed ID: 10744311
[TBL] [Abstract][Full Text] [Related]
13. Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression.
Li H; Meng F; Jiang L; Ren Y; Qiu Z; Yu P; Peng J
Life Sci; 2019 Aug; 231():116548. PubMed ID: 31181228
[TBL] [Abstract][Full Text] [Related]
14. LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species.
Li N; Palandra J; Nemirovskiy OV; Lai Y
Anal Chem; 2009 Mar; 81(6):2251-9. PubMed ID: 19209887
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.
Ni Z; Bikadi Z; Cai X; Rosenberg MF; Mao Q
Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1100-9. PubMed ID: 20739628
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.
Grundy M; Seedhouse C; Russell NH; Pallis M
BMC Cancer; 2011 Jun; 11():254. PubMed ID: 21679421
[TBL] [Abstract][Full Text] [Related]
18. Interaction of oligomeric breast cancer resistant protein (BCRP) with adjudin: a male contraceptive with anti-cancer activity.
Cheng YH; Jenardhanan P; Mathur PP; Qian X; Xia W; Silvestrini B; Cheng CY
Curr Mol Pharmacol; 2014; 7(2):147-53. PubMed ID: 25620224
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective binding of chiral ligands to single nucleotide polymorphisms of the human organic cation transporter-1 determined using cellular membrane affinity chromatography.
Moaddel R; Bighi F; Yamaguchi R; Patel S; Ravichandran S; Wainer IW
Anal Biochem; 2010 Jun; 401(1):148-53. PubMed ID: 20206116
[TBL] [Abstract][Full Text] [Related]
20. In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.
Marchetti S; Oostendorp RL; Pluim D; van Eijndhoven M; van Tellingen O; Schinkel AH; Versace R; Beijnen JH; Mazzanti R; Schellens JH
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3307-13. PubMed ID: 18089724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
